Personal tools

Coexpression cluster:C2454: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C2454_Preadipocyte_Adipocyte_mesenchymal_Fibroblast_Ewing_Sertoli_Synoviocyte |id=C2454 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C2454_Preadipocyte_Adipocyte_mesenchymal_Fibroblast_Ewing_Sertoli_Synoviocyte
|full_id=C2454_Preadipocyte_Adipocyte_mesenchymal_Fibroblast_Ewing_Sertoli_Synoviocyte
|id=C2454
|id=C2454
|ontology_enrichment_celltype=CL:0000192!1.23e-22!42;CL:0000514!1.23e-22!42;CL:0000055!8.84e-22!180;CL:0000680!9.19e-22!57;CL:0000056!9.19e-22!57;CL:0000355!9.19e-22!57;CL:0000359!7.63e-20!32;CL:0000187!1.62e-19!54;CL:0000183!8.51e-17!59;CL:0000393!2.60e-16!60;CL:0000211!2.60e-16!60;CL:0000048!7.53e-14!430;CL:0000723!3.72e-13!436;CL:0000034!2.87e-12!444;CL:0002334!1.12e-10!12;CL:0000057!2.22e-10!75;CL:0002494!8.86e-10!16;CL:0000222!1.72e-09!119;CL:0000136!5.29e-09!15
|ontology_enrichment_disease=DOID:2394!6.33e-11!14
|ontology_enrichment_uberon=UBERON:0001134!1.69e-20!61;UBERON:0002036!1.69e-20!61;UBERON:0003082!1.69e-20!61;UBERON:0002385!1.81e-20!63;UBERON:0001015!1.81e-20!63;UBERON:0000383!1.81e-20!63;UBERON:0004872!1.50e-17!84;UBERON:0004290!5.54e-17!70;UBERON:0001637!1.33e-15!42;UBERON:0003509!1.33e-15!42;UBERON:0004572!1.33e-15!42;UBERON:0000486!1.09e-14!82;UBERON:0004573!2.55e-13!33;UBERON:0004571!2.55e-13!33;UBERON:0000914!5.95e-13!83;UBERON:0002329!5.95e-13!83;UBERON:0003077!5.95e-13!83;UBERON:0003059!5.95e-13!83;UBERON:0007282!5.95e-13!83;UBERON:0009618!5.95e-13!83;UBERON:0007285!5.95e-13!83;UBERON:0001981!6.45e-12!60;UBERON:0007500!6.45e-12!60;UBERON:0004537!6.45e-12!60;UBERON:0006965!6.45e-12!60;UBERON:0004535!1.95e-11!110;UBERON:0000948!3.53e-11!24;UBERON:0005498!3.53e-11!24;UBERON:0004140!3.53e-11!24;UBERON:0009881!3.53e-11!24;UBERON:0004141!3.53e-11!24;UBERON:0003084!3.53e-11!24;UBERON:0007005!3.53e-11!24;UBERON:0004139!3.53e-11!24;UBERON:0004291!3.53e-11!24;UBERON:0001009!9.33e-11!113;UBERON:0000055!7.92e-10!69;UBERON:0002049!1.65e-09!79;UBERON:0007798!1.65e-09!79;UBERON:0007100!2.51e-09!27;UBERON:0000490!4.66e-09!138;UBERON:0003914!2.10e-08!118;UBERON:0005256!4.77e-08!143;UBERON:0003688!5.73e-08!6;UBERON:0002358!5.73e-08!6;UBERON:0003684!5.73e-08!6;UBERON:0001178!5.73e-08!6;UBERON:0004457!2.15e-07!12;UBERON:0000042!2.15e-07!12;UBERON:0001135!3.34e-07!15;UBERON:0002100!5.75e-07!216
}}
}}

Revision as of 14:24, 21 May 2012


Full id: C2454_Preadipocyte_Adipocyte_mesenchymal_Fibroblast_Ewing_Sertoli_Synoviocyte



Phase1 CAGE Peaks

Hg19::chr18:20122740..20122747,+p@chr18:20122740..20122747
+
Hg19::chr3:157205218..157205239,-p@chr3:157205218..157205239
-
Hg19::chr4:178083004..178083050,-p@chr4:178083004..178083050
-
Hg19::chr7:121090011..121090047,+p@chr7:121090011..121090047
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
skeletal muscle tissue1.69e-2061
striated muscle tissue1.69e-2061
myotome1.69e-2061
muscle tissue1.81e-2063
musculature1.81e-2063
musculature of body1.81e-2063
splanchnic layer of lateral plate mesoderm1.50e-1784
dermomyotome5.54e-1770
artery1.33e-1542
arterial blood vessel1.33e-1542
arterial system1.33e-1542
multilaminar epithelium1.09e-1482
systemic artery2.55e-1333
systemic arterial system2.55e-1333
somite5.95e-1383
paraxial mesoderm5.95e-1383
presomitic mesoderm5.95e-1383
presumptive segmental plate5.95e-1383
trunk paraxial mesoderm5.95e-1383
presumptive paraxial mesoderm5.95e-1383
blood vessel6.45e-1260
epithelial tube open at both ends6.45e-1260
blood vasculature6.45e-1260
vascular cord6.45e-1260
cardiovascular system1.95e-11110
heart3.53e-1124
primitive heart tube3.53e-1124
primary heart field3.53e-1124
anterior lateral plate mesoderm3.53e-1124
heart tube3.53e-1124
heart primordium3.53e-1124
cardiac mesoderm3.53e-1124
cardiogenic plate3.53e-1124
heart rudiment3.53e-1124
circulatory system9.33e-11113
vessel7.92e-1069
vasculature1.65e-0979
vascular system1.65e-0979
primary circulatory organ2.51e-0927
unilaminar epithelium4.66e-09138
epithelial tube2.10e-08118
trunk mesenchyme4.77e-08143
omentum5.73e-086
peritoneum5.73e-086
abdominal cavity5.73e-086
visceral peritoneum5.73e-086
cavity lining2.15e-0712
serous membrane2.15e-0712
smooth muscle tissue3.34e-0715
trunk5.75e-07216
Disease
Ontology termp-valuen
ovarian cancer6.33e-1114


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.